Related by context. All words. (Click for frequent words.) 73 immune modulating 72 p# activation 71 cytoprotective 71 kinase inhibition 71 immuno modulatory 71 A3 adenosine receptor 71 effector function 71 selective inhibition 71 erythropoietic 71 ENMD # 71 mediated inhibition 70 Squalamine 70 TNF α 70 Xanafide 70 neurotrophic 70 antiapoptotic 70 prostanoid 70 pathophysiological effects 70 Fc receptor 69 vivo potency 69 adenoviral 69 tumor necrosis 69 myeloproliferative diseases 69 immunomodulatory 69 ADAMTS# 69 pro angiogenic 69 cytostatic 69 haematopoietic 69 SSc 69 antiangiogenic 69 epigenetic therapies 69 AT1R 69 antiproliferative effects 69 Protein Kinase C 69 γ secretase 69 vascular disrupting agents 69 receptor inhibitor 69 p# inhibitor 69 Symadex 69 tumorigenicity 68 ERK1 2 68 plasma pharmacokinetics 68 renal fibrosis 68 CYP #A# 68 eNOS 68 pharmacokinetic interactions 68 ERK signaling 68 antitumor efficacy 68 vWF 68 vidofludimus 68 potent cytotoxic 68 haematologic 68 antiangiogenic agents 68 lenalidomide dexamethasone 68 CCR9 68 proteoglycan 68 demonstrated antitumor activity 68 chemosensitivity 68 cMET 68 interleukin IL -# 68 mitochondrial toxicity 68 flavopiridol 68 selective modulator 68 kidney urologic 68 pharmacodynamic PD 67 isotypes 67 interferon IFN 67 antiangiogenesis 67 PDGFR 67 potent inhibitors 67 microglial activation 67 Cathepsin B 67 p# MAPK 67 cleavable linker 67 antimetabolite 67 pleiotropic effects 67 muscarinic 67 cardioprotection 67 CYT# potent vascular disrupting 67 prognostic markers 67 Th2 cytokines 67 IgG4 67 pharmacodynamic parameters 67 TTR gene 67 immune modulatory 67 CTAP# Capsules 67 CCX# 67 cytolytic 67 tyrosine phosphorylation 67 HDAC inhibition 67 sJIA 67 riociguat 67 XmAb# 67 tryptase 67 neurite outgrowth 67 renoprotective 67 antitumoral 67 antiangiogenic therapy 67 TLE3 67 potent antiproliferative 67 neuroprotection 67 hematological parameters 67 mucociliary clearance 67 amikacin 67 fosbretabulin 67 anti CD3 67 HuLuc# 67 radiosensitivity 67 K ras mutations 67 Treg cell 67 monocytes macrophages 67 selective agonists 67 M1 muscarinic 67 histone deacetylase HDAC 67 immunotoxin 67 interferon γ 67 Interferon beta 67 vinca alkaloid 67 posttranslational modification 67 anti angiogenic agents 67 skeletal metastases 67 GMX# 67 bFGF 67 neurogenic 67 EGFR tyrosine kinase inhibitors 67 immunomodulatory properties 67 orally administered inhibitor 67 heparanase 66 Virulizin ® 66 proapoptotic 66 thalidomide Thalomid 66 fibrotic disease 66 FGFR 66 protein tyrosine kinase 66 GPx 66 granulocyte 66 Clusterin 66 pleiotropic 66 clonal expansion 66 histone deacetylases 66 myelofibrosis polycythemia vera 66 PI3K/mTOR 66 LPA1 receptor 66 apoptotic pathway 66 JAK inhibitors 66 JAK3 66 IL 1β 66 cathepsin B 66 PPARγ 66 Cloretazine VNP#M 66 IL 1ß 66 Gleevec resistant 66 immune modulator 66 tumor antigen 66 immunoregulatory 66 cytopenias 66 endothelial activation 66 antitumor 66 uricase 66 serine threonine 66 TRAIL induced apoptosis 66 anti angiogenic drugs 66 prodrugs 66 cardiogenic 66 metabolomic profiles 66 GSK3B 66 partial agonist 66 SIRT1 activators 66 ara C 66 immunomodulatory effects 66 FLT3 66 TGF beta1 66 neuronal differentiation 66 mTOR inhibitors 66 LHRH antagonists 66 somatostatin 66 intracellular signal transduction 66 hypoxia inducible factor 66 inducible nitric oxide synthase 66 pan HDAC inhibitor 66 antioxidant supplementation 66 androgen receptor AR 66 trastuzumab Herceptin ® 66 allergic inflammation 66 SERMs 66 autophagic 66 small molecule activators 66 cellular immunotherapy 66 PDGF B 66 thrombin receptor 66 constitutively expressed 66 proteasome inhibitor 66 bronchoalveolar lavage 66 biologic therapeutics 66 chimeric monoclonal antibody 66 TLR8 66 transgene expression 66 adipogenic 66 MEK inhibitors 66 antibody mediated 66 AST ALT 66 Kinoid 66 cAMP signaling 66 Chemokine Receptor 66 chemokine receptor 66 CCR2 66 pathophysiological 66 lysosomal 66 lymphangiogenesis 66 CD#b 66 IFN gamma 66 cardiotoxic 66 vasoactive 66 renin angiotensin aldosterone 66 MGd 66 antiarrhythmic 66 upregulates 66 neuronal dysfunction 66 thrombogenic 66 antiangiogenic agent 66 mTOR mammalian target 66 immunoregulation 66 antisense oligonucleotides 66 clonogenic 66 erythropoiesis 66 intracranial hemorrhage ICH 66 glucagon receptor 65 mimetics 65 PDE4 inhibitors 65 mGluR2 NAM 65 anticancer activity 65 apo B 65 #HT#A 65 NS#/#A protease 65 anti leukemic 65 multitargeted 65 carcinoids 65 Aurora kinase 65 gastrointestinal stromal tumors GISTs 65 pharmacodynamic biomarkers 65 ENaC 65 viral kinetics 65 Th2 responses 65 etiologic 65 Akt activation 65 NKG2D 65 Anticalins ® 65 selectively inhibited 65 CDK inhibitor 65 orally bioavailable mimics 65 #beta HSD1 65 anti fibrotic 65 NS4A 65 colon carcinoma 65 cytotoxic effects 65 hypoxic tumors 65 upregulating 65 humanized antibody 65 MYLOTARG 65 preclinically 65 c MET 65 HDACi 65 mineralocorticoid 65 vivo validation 65 glycolipids 65 Cyclin E 65 lesional 65 Oxidative damage 65 Solazed TM 65 metastatic neuroendocrine tumors 65 NAGS deficiency 65 microtubule targeting 65 potency selectivity 65 costimulation 65 JAK2 inhibitor 65 bortezomib Velcade 65 TNFalpha 65 protein tyrosine phosphatase 65 Inosine 65 Darinaparsin 65 calcineurin inhibitors 65 HCV protease inhibitors 65 EGFR HER2 65 p# Shc 65 glutamyl 65 replicase 65 CD# expressing 65 glomerular 65 #ME# 65 Factor Receptor 65 bactericidal activity 65 ligand induced 65 glycosylated 65 pharmacodynamic endpoints 65 xenograft models 65 C5aR 65 DACH platinum 65 busulfan 65 antiproliferative activity 65 endothelial nitric oxide synthase 65 neoplastic 65 mTOR inhibition 65 targeting PCSK9 65 thymidylate synthase TS 65 CD# antibody [001] 65 YONDELIS 65 prostate carcinoma 65 neuroprotective properties 65 Smad3 65 Aviptadil 65 KRAS oncogene 65 thromboxane A2 65 XL# inhibits 65 linear pharmacokinetics 65 innate immune responses 65 oral prodrug 65 inhibitory effects 65 GABAB receptors 65 potent inhibition 65 PNH patients 65 IMiDs R 65 novel VDA molecule 65 OHR/AVR# 65 activin 65 immunopathology 65 glycopeptide 65 murine model 65 HepG2 cells 65 immunoreactivity 65 isoenzyme 65 VEGF inhibitors 65 plasma lipid 65 TPMT 65 redox active 65 PPARg 65 PARP inhibition 65 cathepsins 65 phosphate S1P 65 chronic eosinophilic leukemia 65 pharmacologic intervention 65 humoral immunity 65 lung epithelium 65 endothelin receptor 65 VDAs 65 Fibroblast Growth Factor Receptor 65 CD# monoclonal antibody 65 humanized monoclonal 65 Factor VEGF 65 humoral 65 protein tyrosine phosphatase 1B 65 GHRH 65 epithelial tumors 65 physico chemical properties 65 liposomal formulation 65 hypereosinophilic syndrome 65 FGFs 65 echinocandins 65 TGR5 65 extramedullary 65 airway hyperresponsiveness 65 Epothilones 65 induce apoptosis 65 mitogenic 65 synthetic peptide containing 65 receptor tyrosine kinase inhibitor 65 vitro cytotoxicity 65 PTHrP 65 oncogenesis 65 antitumour 65 VEGF receptor 65 lipid lowering therapies 65 annexin V 65 HIF 1a 65 pathophysiologic 65 dopamine D2 65 myeloperoxidase 65 protein kinase C 65 resolvins 65 galectin 65 small molecule tyrosine 65 immunostimulatory 65 SYN# 65 immunological responses 65 polycystin 1 65 Hsp# inhibitors 64 IAP inhibitor 64 targeted antifolate 64 coronary vasodilation 64 effector functions 64 tumor suppressive 64 lymphoid cells 64 osteogenic 64 cytotoxicity 64 IgG1 antibody 64 FGFR2 64 anti amnesic 64 novel peptide 64 Interferon alpha 64 Upregulation 64 TNFa 64 hypothalamic pituitary 64 benzimidazole 64 cytokine signaling 64 JAK1 64 investigational monoclonal antibody 64 metastatic lymph nodes 64 PI3K inhibitors 64 selective adenosine 64 RAS RAF MEK 64 renal tubular 64 lytic 64 Hypoxia Inducible Factor 64 HCV replicon 64 midkine 64 favorable pharmacokinetic 64 glucose homeostasis 64 Onconase 64 IgG1 antibodies 64 replicon 64 Corgentin 64 #T# L1 64 nucleoside 64 immunostimulatory effects 64 IL #p# 64 prognostic marker 64 PBMCs 64 virologic responses 64 antitumor effect 64 histone deacetylase inhibitor 64 vasodilatory 64 iNOS 64 endogenous ligands 64 PDE# inhibitors 64 soluble tumor necrosis 64 anti angiogenic therapies 64 64 Adrenergic 64 prostate cancer CaP 64 HSP# inhibitors 64 prostaglandin synthesis 64 PTPN# 64 rhITF 64 LNP formulations 64 intracellular signaling pathways 64 enzyme inhibitors 64 C1 INH 64 5 HT6 receptor 64 protein tyrosine phosphatases 64 myeloablative 64 mediated apoptosis 64 radezolid 64 degranulation 64 Solulin 64 KL4 surfactant 64 anti inflammatory cytokine 64 CCR9 antagonist 64 hepatoma 64 extensively metabolized 64 immunomodulating 64 COX2 64 Oncogenic 64 monoclonal antibody mAb 64 MAGE A3 ASCI 64 radiochemotherapy 64 eIF2 64 mineralocorticoid receptor 64 antisense inhibitors 64 serine protease 64 PKCi 64 Angiotensin converting enzyme 64 natriuretic peptides 64 elastase 64 underlying pathophysiology 64 inhibit metastasis 64 VAPRISOL 64 metaplasia 64 druggable 64 constitutively active 64 delafloxacin 64 chromosomal rearrangement 64 NPM1 mutation 64 NF kB pathway 64 sequence homology 64 ß1 64 apoptosis inducing 64 plasma lipoprotein 64 beta lactams 64 potent antitumor 64 humoral responses 64 neovascularization 64 gonadotropins 64 molecularly targeted 64 RNAi therapeutic targeting 64 HQK 64 thyrotropin 64 aberrantly activated 64 OMNARIS HFA 64 CXCR7 64 IMiDs ® 64 beta 1a 64 interleukin IL 64 humanised monoclonal antibody 64 anticancer therapy 64 p# biomarker 64 alkylating 64 glycosylation profile 64 endothelin receptor antagonists 64 treating neuropathic pain 64 PEDF 64 EDEMA3 trial 64 idiopathic myelofibrosis 64 PPAR gamma agonists 64 DCCR 64 doxorubicin HCl 64 annexin 64 phospholipase 64 EGFR pathway 64 Cyclosporine 64 ABL1 64 mutated K ras 64 Factor VIIa 64 molecular biomarkers 64 favorable pharmacokinetic profile 64 lung fibrosis 64 paricalcitol 64 excitotoxic 64 selective agonist 64 Macrophage 64 Fc fusion protein 64 tumoral 64 Tß4 64 antiangiogenic activity 64 missense mutations 64 nucleoside analog 64 RRM1 64 investigational therapies 64 vitro pharmacology 64 metalloprotease 64 inhibiting tumor 64 thienopyridines 64 immunotoxins 64 Temsirolimus 64 HER2 expression 64 gastric carcinoma 64 guanylate cyclase 64 ABCB1 64 DiLA2 64 pathogenetic 64 Estrogen Receptor 64 intranasal delivery 64 antioxidative 64 cyclic adenosine monophosphate cAMP 64 mecamylamine 64 cardiometabolic disorders 64 EndoTAG TM -1 64 HIF 1alpha 64 inverse agonist 64 tyrosine kinase inhibitor 64 synthetic retinoid 64 HSP# inhibitor 64 1α 64 parthenolide 64 HDAC6 64 SGPT 64 Enzastaurin 64 targeting CD# 64 antifolates 64 metastatic malignant 64 fluconazole resistant 64 atypical hemolytic uremic syndrome 64 macrolide antibiotic 64 deacetylase inhibitors 64 AEG# 64 Multimeric 64 liposome formulation 64 spermidine 64 tigecycline 64 Src inhibitors 64 chemopreventive agent 64 hepatotoxic 64 Anticalins R 64 idarubicin 64 STAT3 signaling 64 geldanamycin 64 P#X# 64 immune stimulatory 64 capsular polysaccharide 64 Telintra 64 Dalbavancin 64 TG# [003] 64 RNA antagonist 64 PlGF 64 mutational status 64 CEACAM1 64 heterologous 64 HLA DRB1 * 64 FUSILEV enhances 64 prognostic indicators 64 beta lactam antibiotic 64 sphingolipid 64 Dysregulation 64 antitumor effects 64 Altastaph 64 Azedra 64 MP4OX 64 R Saizen R 64 Fludara ® 64 clinicopathological 64 SIRT2 64 cell adhesion molecule 64 IFN beta 64 miRs 64 Leydig cell 64 differential gene expression 64 insulin sensitizing 64 Alfacell proprietary ribonuclease 64 antimitotic 64 anticancer therapies 64 mGluR5 antagonist 64 anti proliferative 64 Granulocyte Colony Stimulating Factor 64 cyclooxygenase 2 64 Vidaza azacitidine 64 NMDA antagonists 64 potent anticancer 64 IFN γ 64 vascular endothelial 64 erlotinib Tarceva ® 64 JAK2 enzyme 64 myopathies 64 mda 7 64 Carfilzomib 64 p# mitogen activated 64 gefitinib Iressa 64 neuroinflammatory 64 hepatic fibrosis 64 proteolytic cleavage 64 cardioprotective effects 64 TGF ß 64 serum antibodies 64 pegylated liposomal doxorubicin 64 peptidic 64 stimulate insulin secretion 64 vitro assay 64 LPS induced 64 levodopa carbidopa 64 K RAS 63 retinoid X 63 pertussis toxin 63 colorectal carcinogenesis 63 cerebral ischemia 63 porcine derived 63 MAPK pathway 63 lymphotoxin 63 JAK#/JAK# 63 Alpha lipoic acid 63 FKBP# 63 TroVax ® 63 cytokines IL 63 solubilization 63 unresectable tumors 63 isoenzymes 63 quinolone 63 RhuDex ® 63 INCB# [001] 63 osteoblastic 63 estrogen receptor beta 63 phenotypic expression 63 Cytotoxic 63 pDCs 63 proliferative diseases 63 pharmacologic approaches 63 imatinib Gleevec 63 downregulating 63 alpha#beta# integrin 63 CYP #D# 63 dimeric 63 nicotinic acetylcholine receptor 63 RhuDex R 63 investigational humanized monoclonal antibody 63 Cardiotoxicity 63 small molecule activator 63 ACh 63 Aurora Kinase 63 hemoglobinopathies 63 acadesine 63 Zollinger Ellison Syndrome 63 demyelinating 63 null responder 63 Bezielle 63 tumorigenic 63 IL #R 63 serine proteases 63 prognostic indicator 63 Chinese Hamster Ovary 63 ectopic expression 63 Panzem R NCD 63 Glucocorticoids 63 CD4 + CD# 63 proliferative disorders 63 BEXXAR Therapeutic Regimen 63 therapeutic regimens 63 kallikrein 63 tolerogenic 63 coagulopathy 63 IFN g 63 hERG 63 antibiofilm 63 synthase TS 63 humanized anti 63 Pegylated 63 engineered RAP peptides 63 neutropenic patients 63 immunomodulatory therapy 63 rhIL 7 63 aT cell 63 thrombopoietin 63 CsA 63 antithrombotic 63 lymphocyte activation 63 TRAIL R1 63 monomeric 63 HER2 overexpression 63 cardiac repolarization 63 immunodeficiencies 63 immunoglobulin G 63 gemifloxacin 63 splice variants 63 PEG SN# 63 pegylated 63 IMiDs ® compound 63 Nod1 63 antibody cytokine 63 TRV# [001] 63 Neuropeptide Y 63 colony stimulating factor 63 PDE4 inhibitor 63 Antitumor 63 muscarinic receptors 63 R baclofen 63 HbF 63 rxRNA 63 paraneoplastic 63 alkylating agent 63 TMEM#B 63 glucocorticoid receptor 63 potent inhibitory 63 antiproliferative 63 VEGFR1 63 FGFR4 63 fatty acid oxidation 63 DNA methyltransferases 63 bispecific 63 N methyl 63 small molecule thrombopoietin 63 ALV# 63 coexpression 63 isoform selective 63 alagebrium 63 CCR1 63 E. histolytica 63 lymphoid tumors 63 5 HT4 receptor 63 MTP inhibitor 63 Nanobody ® 63 EGFR tyrosine kinase inhibitor 63 L asparaginase 63 ELACYT 63 CRAC channel 63 clevidipine 63 Sgk1 63 vaso occlusive crisis 63 neoplastic diseases 63 mevalonate 63 downregulation 63 anti atherogenic 63 Immunotherapeutic 63 Anticalin ® 63 pathogenic mechanisms 63 DNA demethylation 63 receptor subtype 63 gemcitabine Gemzar 63 tRNA synthetases 63 Flt3 63 Lenalidomide 63 receptor subtypes 63 mechanistic insights 63 immunomodulator 63 sCD# 63 imatinib therapy 63 adrenoceptor 63 IFN β 63 Tasigna prolongs 63 Valortim ® 63 proteolytic enzymes 63 direct thrombin inhibitors 63 calcineurin inhibitor 63 glutathione GSH 63 somatostatin receptors 63 posttranslational modifications 63 imatinib resistance 63 plasma kallikrein inhibitor 63 antiinflammatory 63 Panzem R 63 secondary hyperparathyroidism 63 Doxil ® 63 potent inducer 63 T#M mutation 63 HIF 1α 63 CB2 receptor 63 immune modulators 63 antimetastatic 63 mTOR signaling 63 candidemia 63 LHRH receptor positive 63 synaptogenesis 63 IgG1 63 LRP5 63 pyrimidines 63 enzymatic activity 63 selective antagonist 63 drug metabolizing enzymes 63 intensive lipid lowering 63 TNF Tumor Necrosis Factor 63 receptor monoclonal antibody 63 A2A receptor 63 HER1 63 Hsp# inhibition 63 ERK activation 63 thymidylate synthase 63 mesenchymal cell 63 uPA 63 Incretin 63 potentiator 63 ESBA# 63 azacytidine 63 peptide antigens 63 antifibrotic 63 apolipoprotein AI 63 HIF PH 63 bleomycin 63 delipidation 63 secretory pathway 63 metaglidasen 63 histone deacetylase 63 druggable target 63 nicardipine 63 hematopoietic cell 63 hMG 63 immune modulation 63 siRNA therapeutics 63 EGFR inhibitors 63 LT NS# 63 cardiac contractility 63 HMG CoA reductase inhibitors 63 cytotoxicity assays 63 molecular determinants 63 proteomic analysis 63 hepatic encephalopathy HE 63 NTDDS 63 papillary renal cell carcinoma 63 Nampt 63 TIMP 1 63 ERK phosphorylation 63 EGFR TKIs 63 CCL# 63 mGlu2 3 63 varespladib 63 vasodilatation 63 GRNCM1 63 PI3K inhibitor 63 neuroprotectant 63 proinflammatory 63 bladder carcinoma 63 PRT# 63 angiogenic therapy 63 IFN alpha 63 Sezary syndrome 63 mitochondrial metabolism 63 Elevated serum 63 non nucleoside 63 Nilotinib 63 lenalidomide Revlimid R 63 CYP#A# CYP#D# 63 TLR agonists 63 somatostatin receptor 63 beta interferons 63 griseofulvin 63 peroxisomal 63 Enkephalin 63 EGF receptor 63 sitaxsentan 63 N. gonorrhoeae 63 neuroactive 63 somatostatin analogue 63 outer membrane proteins 63 Eg5 63 virulence genes 63 factor HGF 63 cyclin dependent kinase inhibitor 63 mitogen activated protein kinase 63 c myc gene 63 G6PD deficiency 63 immune suppressive 63 anti CD3 antibody 63 prostacyclins 63 5 HT2A serotonin 63 polymerase inhibitors 63 factor PlGF 63 FGFR1 63 lysophosphatidic acid LPA 63 intracellular signaling 63 myeloproliferative disorders 63 TNF alpha antagonist 63 viral pathogenesis 63 oncoproteins 63 ziconotide 63 rifamycins 63 histone acetylation 63 activating mutations 63 Aplidin 63 fatty acid biosynthesis 63 GLP 1R 63 dose proportionality 63 immunological 63 lupus anticoagulant 63 AZT zidovudine Retrovir 63 trans retinoic acid 63 hA# 63 5 HT2C 63 autoimmune inflammatory 63 endotoxemia 63 cisplatin gemcitabine 63 AAG geldanamycin analog 63 prognostic biomarker 63 neuropsychiatric diseases 63 oxysterols 63 calcitonin gene related 63 chemoprotective 63 nucleoside analogues 63 IFN α 63 PDE1 63 5alpha reductase 63 FGF2 63 airway remodeling 63 VIPR2 63 CobaCyte 63 Tyrima 63 immunotoxicity 63 adrenal suppression 63 underlying vasculopathy 63 PLX cells 63 enzyme cofactor 63 EGFr 63 agonists antagonists 63 sGC 63 HCV protease 63 factor Xa 63 mRCC 63 OvaRex R 63 mycosis fungoides 63 nalbuphine ER 63 intratumoral 63 Superoxide 63 cytochrome P 63 intestinal mucosa 63 anti secretory 63 pathophysiological mechanisms 63 alpha7 63 PHD2 63 mycobacterial 63 Fas ligand 63 Dasatinib 63 overactivation 63 Overexpression 63 Amino acid 63 breast cancer subtypes 63 BXT # 63 diabetic kidney 63 stimulate neurogenesis 63 Pseudomonas aeruginosa infections 63 acetyltransferase 63 Vascugel 63 selectively inhibit 63 nonischemic 63 Liprotamase 63 prostate epithelial cells 63 NXL# 63 recombinant antibodies 63 PON1 63 Teriflunomide 63 evolutionarily conserved 63 inactivating mutations 63 N Myc 63 cilengitide 63 taxane resistant 63 hENT1 63 tissue fibrosis 63 4E BP1